Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Boosting vaccine for tuberculosis.

J V Brooks1, A A Frank, M A Keen

  • 1Mycobacteria Research Laboratories, Colorado State University, Fort Collins, Colorado 80523, USA.

Infection and Immunity
|March 20, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Determination of lesion volume by MRI and stereology in a macaque model of tuberculosis.

Tuberculosis (Edinburgh, Scotland)·2009
Same author

Animal models of mycobacteria infection.

Current protocols in immunology·2008
Same author

Gamma interferon production by bovine gamma delta T cells following stimulation with mycobacterial mycolylarabinogalactan peptidoglycan.

Infection and immunity·2004
Same author

Toll-like receptor 4 plays no role in susceptibility of mice to Mycobacterium tuberculosis infection.

Tuberculosis (Edinburgh, Scotland)·2003
Same author

The mouse as a useful model of tuberculosis.

Tuberculosis (Edinburgh, Scotland)·2003
Same author

Activation marker expression on bovine peripheral blood gammadelta T cells during post-natal development and following vaccination with a commercial polyvalent viral vaccine.

Developmental and comparative immunology·2003
Same journal

<i>Porphyromonas gingivalis</i> sphingolipids affect early responses of THP-1 macrophages to outer membrane vesicles.

Infection and immunity·2026
Same journal

A genome-wide CRISPR screen defines host determinants of early <i>Brucella</i> infection in human macrophage-like cells.

Infection and immunity·2026
Same journal

Antiphospholipid antibodies in acute and post-treatment Lyme disease.

Infection and immunity·2026
Same journal

The cholesterol-dependent cytolysin promotes <i>Streptococcus</i> systemic spread and induces arachidonic acid accumulation-mediated lethality in a murine intraperitoneal infection model.

Infection and immunity·2026
Same journal

Phenotypic and genotypic analysis of <i>Candida albicans</i> vaginal isolates reveals that <i>ECE1</i> expression underpins pathogenicity.

Infection and immunity·2026
Same journal

<i>Staphylococcus aureus</i> pore-forming toxins differentially shape disease severity in experimental endophthalmitis.

Infection and immunity·2026
See all related articles

Boosting BCG-vaccinated mice with a specific protein restores tuberculosis resistance in aging. This protein enhances lung protection and reduces disease severity in older, vaccinated individuals.

Area of Science:

  • Immunology
  • Vaccinology
  • Microbiology

Background:

  • Tuberculosis (TB) remains a significant global health challenge, necessitating improved control strategies.
  • Current research focuses on novel prophylactic and therapeutic vaccines, neglecting the potential for boosting existing immunity.
  • Bacille Calmette-Guérin (BCG) vaccination is widely used but its protective efficacy wanes over time.

Purpose of the Study:

  • To investigate the potential of boosting BCG-vaccinated individuals to restore tuberculosis resistance.
  • To evaluate the efficacy of the 30-kDa mycolyl transferase A protein as a booster vaccine.

Main Methods:

  • Mice were vaccinated with BCG and allowed to age, simulating waning immunity.
  • Aging, BCG-vaccinated mice received a midlife inoculation with the 30-kDa mycolyl transferase A protein.

Related Experiment Videos

  • Both boosted and unboosted aged mice were challenged with Mycobacterium tuberculosis via aerosol.

    • Main Results:

    • BCG-vaccinated mice showed decreased resistance to aerosol TB challenge with age.
    • Midlife inoculation with the 30-kDa mycolyl transferase A protein restored protective immunity in aged mice.
    • Boosted mice exhibited lung protection levels comparable to young mice, with significantly reduced pathology.

    Conclusions:

    • Boosting aged, BCG-vaccinated individuals with the 30-kDa mycolyl transferase A protein can effectively restore tuberculosis resistance.
    • This approach offers a promising strategy to enhance long-term protection against TB in previously vaccinated populations.